Summary
- Current Price
- As of today, PCVX price is $61.61, down -2.78% on
- Current Price All-Time High
- PCVX price is currently -49.11% below its historical high of $121.06 set on
- Market Cap
- PCVX current market cap is $10B, up +54.05% over the past 365 days
- Revenue
- PCVX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for PCVX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Vaxcyte, Inc. |
| Ticker | NASDAQ: PCVX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vaxcyte.com |
| Employees | 414 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $61.61 | |
| Price, 1D Change | -2.78% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.27 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$5.63 | |
| EPS, 1Y Change | -48.14% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$5.63 | |
| EPS Estimate | -$7.86 | |
| EPS Est. Change | -39.45% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $61.61 | |
| Price Target | $121.00 | - |
| Price Tgt. Change | +96.40% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.91 | -$3.80 | +2.84% | |
| -$5.28 | -$5.63 | -6.69% | |
| -$7.86 | N/A | -39.45% | |
| -$6.62 | N/A | -17.57% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $68.89M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +26.54% | |
| Price, 3Y | +23.00% | |
| Market Cap, 1Y | +54.05% | |
| Market Cap, 3Y | +104.74% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -48.14% | |
| EPS, 3Y | -63.54% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $61.61 | |
| SMA 200 | $57.74 | |
| SMA 50 | $62.24 | |
| EMA 200 | $57.51 | |
| EMA 50 | $62.48 | |
| MACD | $0.47 | |
| Beta | 1.27 | |
| ATR | $3.31 | |
| 14-Day RSI | 46.53 | |
| 10-Day Volatility | 74.48% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$5.63 | |
| Gross Profit | -$24.86M | |
| - | ||
| Operating Income | -$923.68M | |
| - | ||
| Net Income | -$766.63M | |
| - | ||
| EBITDA | -$898.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.04 | |
| 7.91 | ||
| 7.91 | ||
| - | ||
| - | ||
| 14.80 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 3.92 | ||
| -7.23 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $2.69B | |
| $1.56B | ||
| $3.05B | ||
| $1.63B | ||
| $360.46M | ||
| $205.75M | ||
| Total Debt | $117.48M | |
| $6.12M | ||
| $70.90M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $766.63M | ||
| $898.82M | ||
| $24.86M | ||
| $0.00 | ||
| $24.86M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$655.58M | ||
| $437.35M | ||
| $2.01M | ||
| Capex | $56.97M | |
| -$712.55M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Cantor Fitzgerald | → | |
| Needham | → | |
| Guggenheim | → | |
| BTIG | → | |
| B of A Securities | → | |
| Needham | → | |
| BTIG | → | |
| Guggenheim | → | |
| BTIG | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PCVX
FAQ
- What is the ticker symbol for Vaxcyte, Inc.?
- The ticker symbol for Vaxcyte, Inc. is NASDAQ:PCVX
- Does Vaxcyte, Inc. pay dividends?
- No, Vaxcyte, Inc. does not pay dividends
- What sector is Vaxcyte, Inc. in?
- Vaxcyte, Inc. is in the Healthcare sector
- What industry is Vaxcyte, Inc. in?
- Vaxcyte, Inc. is in the Biotechnology industry
- What country is Vaxcyte, Inc. based in?
- Vaxcyte, Inc. is headquartered in United States
- When did Vaxcyte, Inc. go public?
- Vaxcyte, Inc. initial public offering (IPO) was on June 12, 2020
- Is Vaxcyte, Inc. in the S&P 500?
- No, Vaxcyte, Inc. is not included in the S&P 500 index
- Is Vaxcyte, Inc. in the NASDAQ 100?
- No, Vaxcyte, Inc. is not included in the NASDAQ 100 index
- Is Vaxcyte, Inc. in the Dow Jones?
- No, Vaxcyte, Inc. is not included in the Dow Jones index
- When was Vaxcyte, Inc. last earnings report?
- Vaxcyte, Inc.'s most recent earnings report was on November 4, 2026
- When does Vaxcyte, Inc. report earnings?
- The next expected earnings date for Vaxcyte, Inc. is February 23, 2027
Data Sources & References
- PCVX Official Website vaxcyte.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm
- PCVX Profile on Yahoo Finance finance.yahoo.com/quote/PCVX
- PCVX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pcvx
